Akebia Therapeutics
AKBA
$1.34
Share price
0.75%
Change (1 day)
69.62%
Change (1 year)
Categories
Number of shares outstanding for Akebia Therapeutics (AKBA)
Number of shares outstanding as of April 2024 : 188,306,350
According to Akebia Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 188,306,350. At the end of 2023 the company had 188,306,350 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Akebia Therapeutics from 2013 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.18 B | 2.35% |
| 2022 | 0.18 B | 4.77% |
| 2021 | 0.17 B | 21.01% |
| 2020 | 0.14 B | 21.58% |
| 2019 | 0.11 B | 2.11% |
| 2018 | 0.11 B | 149.02% |
| 2017 | 46.93 M | 23.86% |
| 2016 | 37.89 M | 31.66% |
| 2015 | 28.78 M | 46.18% |
| 2014 | 19.69 M | 94.34% |
| 2013 | 10.13 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 1,178.34% | 🇺🇸 USA |
 Novartis NVS | 2,062,000,000 | 995.02% | 🇨🇭 Switzerland |
 Amgen AMGN | 535,000,000 | 184.11% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | 190,406,000 | 1.12% | 🇺🇸 USA |